BioCentury
ARTICLE | Company News

Anabasis, Dompe SpA deal

March 5, 2012 8:00 AM UTC

Dompe will acquire the 51% of partner Anabasis it does not already own for an undisclosed amount, including an upfront payment and milestones related to Anabasis' ophthalmic formulation of nerve grow...